CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CHECKMATE PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 37 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2021$233,000
+53.3%
19,146
+84.5%
0.00%–
Q4 2020$152,000
+26.7%
10,3790.0%0.00%–
Q3 2020$120,000–10,379–0.00%–
 Download
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 0$00.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders